| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 137, 5456-5462, Copyright © 1996 by Endocrine Society
ARTICLES |
MA Leff, DJ Buckley, JS Krumenacker, JC Reed, T Miyashita and AR Buckley
Department of Pharmacology and Toxicology, University of North Dakota School of Medicine, Grand Forks 58202-9037, USA.
The Nb2 rat lymphoma represents a useful model for investigation of molecular events coupled to PRL-induced proliferation. Moreover, recent evidence has also demonstrated the utility of this system to study mechanisms linked to programmed cell death (apoptosis). Thus, glucocorticosteroids activate apoptosis in lactogen-dependent Nb2 cells, whereas the addition of PRL abrogates this effect. The present study was conducted to determine whether PRL stimulation in lactogen- dependent Nb2-11 or autonomous Nb2-SFJCD1 cultures alters expression of bcl-2 or bax, genes that suppress or facilitate apoptosis, respectively. We demonstrate that PRL stimulation in stationary Nb2-11 cultures significantly increased the level of bcl-2 messenger RNA (mRNA) within 3 h (15-fold) and its protein product by 6 h, time points previously shown to correspond with G1 cell cycle progression. In Nb2- SFJCD1 cells, bcl-2 mRNA was found to be constitutively present. Addition of PRL to these lactogen-independent cultures further enhanced its expression at the mRNA and protein levels with a kinetic pattern similar to that observed in the PRL-dependent line. Results from stability studies indicated that increased bcl-2 mRNA evoked by PRL in Nb2 cell lines was most likely not attributable to increased stability of its transcripts. Furthermore, the rapid increase in its expression in PRL-stimulated Nb2-11 cells was not altered by inhibition of protein synthesis suggesting a direct action of the hormone. PRL also increased bax mRNA by 8 h in Nb2-11 cultures. However, hormone stimulation markedly attenuated the level of the Bax protein from 2-6 h. In contrast, bax expression in Nb2-SFJCD1 cultures remained unaltered by the addition of the hormone. These results demonstrate that altered expression of bcl-2 and bax are each associated with PRL-stimulated cell cycle progression in Nb2 cells. Moreover, bcl-2 appears to be an immediate-early gene induced by PRL in the hormone-dependent line and may represent an important regulator of early G1 cell cycle progression most likely by suppressing cell death mechanisms.
This article has been cited by other articles:
 |
|
 |
|
  V. L. Williams, A. DeGuzman, H. Dang, M. Kawaminami, T. W. C. Ho, D. G. Carter, and A. M. Walker Common and specific effects of the two major forms of prolactin in the rat testis Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1795 - E1803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Fujinaka, K. Takane, H. Yamashita, and R. C. Vasavada Lactogens Promote Beta Cell Survival through JAK2/STAT5 Activation and Bcl-XL Upregulation J. Biol. Chem., October 19, 2007; 282(42): 30707 - 30717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Peeva, J. Gonzalez, R. Hicks, and B. Diamond Cutting Edge: Lupus Susceptibility Interval Sle3/5 Confers Responsiveness to Prolactin in C57BL/6 Mice J. Immunol., August 1, 2006; 177(3): 1401 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Felmet, M. W. Hall, R. S. B. Clark, R. Jaffe, and J. A. Carcillo Prolonged Lymphopenia, Lymphoid Depletion, and Hypoprolactinemia in Children with Nosocomial Sepsis and Multiple Organ Failure J. Immunol., March 15, 2005; 174(6): 3765 - 3772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gerlo, P. Verdood, B. Gellersen, E. L. Hooghe-Peters, and R. Kooijman Mechanism of Prostaglandin (PG)E2-Induced Prolactin Expression in Human T Cells: Cooperation of Two PGE2 Receptor Subtypes, E-Prostanoid (EP) 3 and EP4, Via Calcium- and Cyclic Adenosine 5'-Monophosphate-Mediated Signaling Pathways J. Immunol., November 15, 2004; 173(10): 5952 - 5962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Krishnan, O. Thellin, D. J. Buckley, N. D. Horseman, and A. R. Buckley Prolactin Suppresses Glucocorticoid-Induced Thymocyte Apoptosis in Vivo Endocrinology, May 1, 2003; 144(5): 2102 - 2110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A R Buckley Prolactin, a lymphocyte growth and survival factor Lupus, October 1, 2001; 10(10): 684 - 690. [Abstract] [PDF]
|
|
|
|
|
|
L. Welniak, S. Richards, and W. Murphy Effects of prolactin on hematopoiesis Lupus, October 1, 2001; 10(10): 700 - 705. [Abstract] [PDF]
|
|
|
|
|
|
C. Tessier, A. Prigent-Tessier, S. Ferguson-Gottschall, Y. Gu, and G. Gibori PRL Antiapoptotic Effect in the Rat Decidua Involves the PI3K/Protein Kinase B-Mediated Inhibition of Caspase-3 Activity Endocrinology, September 1, 2001; 142(9): 4086 - 4094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A M Jacobi, W Rohde, H-D Volk, T Dorner, G-R Burmester, and F Hiepe Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls Ann Rheum Dis, March 1, 2001; 60(3): 242 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. Murphy, M. Limoges, F. Dodd, R. T. M. Boudreau, and C. K. L. Too Fibroblast Growth Factor-2 Stimulates Endothelial Nitric Oxide Synthase Expression and Inhibits Apoptosis by a Nitric Oxide-Dependent Pathway in Nb2 Lymphoma Cells Endocrinology, January 1, 2001; 142(1): 81 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Van Coppenolle, C. Slomianny, F. Carpentier, X. Le Bourhis, A. Ahidouch, D. Croix, G. Legrand, E. Dewailly, S. Fournier, H. Cousse, et al. Effects of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependence Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E120 - E129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Dorshkind and N. D. Horseman The Roles of Prolactin, Growth Hormone, Insulin-Like Growth Factor-I, and Thyroid Hormones in Lymphocyte Development and Function: Insights from Genetic Models of Hormone and Hormone Receptor Deficiency Endocr. Rev., June 1, 2000; 21(3): 292 - 312. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Kanasaki, K. Fukunaga, K. Takahashi, K. Miyazaki, and E. Miyamoto Involvement of p38 Mitogen-Activated Protein Kinase Activation in Bromocriptine-Induced Apoptosis in Rat Pituitary GH3 Cells Biol Reprod, June 1, 2000; 62(6): 1486 - 1494. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Jeay, G. E. Sonenshein, M.-C. Postel-Vinay, and E. Baixeras Growth Hormone Prevents Apoptosis through Activation of Nuclear Factor-{kappa}B in Interleukin-3-Dependent Ba/F3 Cell Line Mol. Endocrinol., May 1, 2000; 14(5): 650 - 661. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. R. BUCKLEY and D. J. BUCKLEY Prolactin Regulation of Apoptosis-Associated Gene Expression in T Cells Ann. N.Y. Acad. Sci., January 1, 2000; 917(1): 522 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhang, M. J. Blake, P. W. Gout, D. J. Buckley, and A. R. Buckley Proteolysis of Heat Shock Transcription Factor Is Associated with Apoptosis in Rat Nb2 Lymphoma Cells Cell Growth Differ., November 1, 1999; 10(11): 759 - 767. [Abstract] [Full Text]
|
|
|
|
|
|
T. J. Ahonen, P. L. Härkönen, J. Laine, H. Rui, P. M. Martikainen, and M. T. Nevalainen Prolactin Is a Survival Factor for Androgen-Deprived Rat Dorsal and Lateral Prostate Epithelium in Organ Culture Endocrinology, November 1, 1999; 140(11): 5412 - 5421. [Abstract] [Full Text]
|
|
|
|
|
|
R. C. Humphreys and L. Hennighausen Signal Transducer and Activator of Transcription 5a Influences Mammary Epithelial Cell Survival and Tumorigenesis Cell Growth Differ., October 1, 1999; 10(10): 685 - 694. [Abstract] [Full Text]
|
|
|
|
|
|
P. Morales, M. V. Carretero, H. Geronimo, S. G. Copín, M. L. Gaspar, M. A. R. Marcos, and J. Martín-Pérez Influence of Prolactin on the Differentiation of Mouse B-Lymphoid Precursors Cell Growth Differ., August 1, 1999; 10(8): 583 - 590. [Abstract] [Full Text]
|
|
|
|
|
|
E. L. K. Goh, T. J. Pircher, and P. E. Lobie Growth Hormone Promotion of Tubulin Polymerization Stabilizes the Microtubule Network and Protects Against Colchicine-Induced Apoptosis Endocrinology, October 1, 1998; 139(10): 4364 - 4372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sugino, M. Hirosawa-Takamori, L. Zhong, C. M. Telleria, K. Shiota, and G. Gibori Hormonal Regulation of Copper-Zinc Superoxide Dismutase and Manganese Superoxide Dismutase Messenger Ribonucleic Acid in the Rat Corpus Luteum: Induction by Prolactin and Placental Lactogens Biol Reprod, July 1, 1998; 59(3): 599 - 605. [Abstract] [Full Text]
|
|
|
|
|
|
C. Bole-Feysot, V. Goffin, M. Edery, N. Binart, and P. A. Kelly Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice Endocr. Rev., June 1, 1998; 19(3): 225 - 268. [Abstract] [Full Text]
|
|
|
|
 |
|
 W.-P. Chang, Y. Ye, and C. V. Clevenger Stoichiometric Structure-Function Analysis of the Prolactin Receptor Signaling Domain by Receptor Chimeras Mol. Cell. Biol., February 1, 1998; 18(2): 896 - 905. [Abstract] [Full Text]
|
|
|
|
|
|
C. V. Clevenger, K. Thickman, W. Ngo, W.-P. Chang, S. Takayama, and J. C. Reed Role of Bag-1 in the Survival and Proliferation of the Cytokine-Dependent Lymphocyte Lines, Ba/F3 and Nb2 Mol. Endocrinol., May 1, 1997; 11(5): 608 - 618. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
